Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Ioannides, CG' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 40 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Castilleja, A; Ward, NE; O'Brian, CA; Swearingen, B; Swan, E; Gillogly, MA; Murray, JL; Kudelka, AP; Gershenson, DM; Ioannides, CG
      Accelerated HER-2 degradation enhanced ovarian tumor recognition by CTL. Implications for tumor immunogenicity

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    2. Murray, JL; Hudson, JM; Ross, MI; Zhang, HZ; Ioannides, CG
      Reduced recognition of metastatic melanoma cells by autologous MART-1 specific CTL: Relationship to TAP expression

      JOURNAL OF IMMUNOTHERAPY
    3. Lee, TV; Kim, DK; Peoples, GE; Castilleja, A; Murray, JL; Gershenson, DM; Ioannides, CG
      Secretion of CXC chemokine IP-10 by peripheral blood mononuclear cells from healthy donors and breast cancer patients stimulated with HER-2 peptides

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    4. Anderson, BW; Peoples, GE; Murray, JL; Gillogly, MA; Gershenson, DM; Ioannides, CG
      Peptide priming of cytolytic activity to HER-2 epitope 369-377 in healthy individuals

      CLINICAL CANCER RESEARCH
    5. Lee, TV; Anderson, BW; Peoples, GE; Castilleja, A; Murray, JL; Gershenson, DM; Ioannides, CG
      Identification of activated tumor antigen-reactive CD8(+) cells in healthyindividuals

      ONCOLOGY REPORTS
    6. Yen, N; Ioannides, CG; Xu, K; Swisher, SG; Lawrence, DD; Kemp, BL; El-Naggar, AK; Cristiano, RJ; Fang, BL; Glisson, BS; Hong, WK; Khuri, FR; Kurie, JM; Lee, JJ; Lee, JS; Merritt, JA; Mukhopadhyay, T; Nesbitt, JC; Nguyen, D; Perez-Soler, R; Pisters, KMW; Putnam, JB; Schrump, DS; Shin, DM; Walsh, GL; Roth, JA
      Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type p53 (Ad-p53)

      CANCER GENE THERAPY
    7. Anderson, RW; Kudelka, AP; Honda, T; Pollack, MS; Gershenson, DM; Gillogly, MA; Murray, JL; Ioannides, CG
      Induction of determinant spreading and of Th1 responses by in vitro stimulation with HER-2 peptides

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    8. Murray, JL; Przepiorka, D; Ioannides, CG
      Clinical trials of HER-2/neu-specific vaccines

      SEMINARS IN ONCOLOGY
    9. Ward, NE; Stewart, JR; Ioannides, CG; O'Brian, CA
      Oxidant-induced S-gutathiolation inactivates protein kinase C-alpha (PKC-alpha): A potential mechanism of PKC isozyme regulation

      BIOCHEMISTRY
    10. Peoples, GE; Anderson, BW; Lee, TV; Murray, JL; Kudelka, AP; Wharton, JT; Ioannides, CG
      Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers

      CLINICAL CANCER RESEARCH
    11. Anderson, LD; Hudson, JM; Savary, CA; Fisk, B; Gershenson, DM; Ioannides, CG
      HER-2/neu peptide specificity in the recognition of HLA-A2 by natural killer cells

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    12. Kim, DK; Lee, TV; Castilleja, A; Anderson, BW; Peoples, GE; Kudelka, AP; Murray, JL; Sittisomwong, T; Wharton, JT; Kim, JW; Ioannides, CG
      Folate binding protein peptide 191-199 presented on dendritic cells can stimulate CTL from ovarian and breast cancer patients

      ANTICANCER RESEARCH
    13. Stewart, JR; Ward, NE; Ioannides, CG; O'Brian, CA
      Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism

      BIOCHEMISTRY
    14. HUDSON JM; CASTILLEJA A; MURRAY JL; HONDA T; KUDELKA A; SINGLETARY E; WHARTON JT; IOANNIDES CG
      GROWTH AND ANTIGEN RECOGNITION OF TUMOR-INFILTRATING LYMPHOCYTES FROMHUMAN BREAST-CANCER

      Journal of interferon & cytokine research
    15. TUTTLE TM; ANDERSON BW; THOMPSON WE; LEE JE; SAHIN A; SMITH TL; GRABSTEIN KH; WHARTON JT; IOANNIDES CG; MURRAY JL
      PROLIFERATIVE AND CYTOKINE RESPONSES TO CLASS-II HER-2 NEU-ASSOCIATEDPEPTIDES IN BREAST-CANCER PATIENTS/

      Clinical cancer research
    16. Peoples, GE; Anderson, BW; Fisk, B; Kudelka, AP; Wharton, JT; Ioannides, CG
      Ovarian cancer-associated lymphocyte recognition of folate binding proteinpeptides

      ANNALS OF SURGICAL ONCOLOGY
    17. CASTILLEJA A; OBRIAN CA; ANDERSON BW; WHARTON JT; IOANNIDES CG
      INHIBITION OF CTL EPITOPE PRESENTATION AND TUMOR IMMUNOGENICITY BY HER-2 TYROSINE PHOSPHORYLATION

      The FASEB journal
    18. Babcock, B; Anderson, BW; Papayannopoulos, I; Castilleja, A; Murray, JL; Stifani, S; Kudelka, AP; Wharton, JT; Ioannides, CG
      Ovarian and breast cytotoxic T lymphocytes can recognize peptides from theamino enhancer of split protein of the Notch complex

      MOLECULAR IMMUNOLOGY
    19. FISK B; IOANNIDES CG
      INCREASED SENSITIVITY OF ADRIAMYCIN-SELECTED TUMOR LINES TO CTL-MEDIATED LYSIS RESULTS IN ENHANCED DRUG-SENSITIVITY

      Cancer research
    20. FISK B; DAGUE B; SEIFERT WE; KUDELKA AP; WHARTON JT; MURRAY JL; IOANNIDES CG
      MASS-SPECTROMETRIC ANALYSIS OF NATURALLY PROCESSED PEPTIDES RECOGNIZED BY OVARIAN TUMOR-ASSOCIATED CD8(+) CTL

      International journal of oncology
    21. FISK B; HUDSON M; KAVANAGH J; WHARTON JT; MURRAY JL; IOANNIDES CG; KUDELKA AP
      EXISTENT PROLIFERATIVE RESPONSES OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM HEALTHY DONORS AND OVARIAN-CANCER PATIENTS TO HER-2 PEPTIDES

      Anticancer research
    22. TUTTLE TM; THOMPSON WE; ANDERSON BW; LEE JE; GRABSTEIN KW; MURRAY JL; WHARTON JT; IOANNIDES CG
      HER-2 NEU PEPTIDE INDUCES TH1 RESPONSES IN ASSOCIATION WITH HLA-DR4 IN BREAST-CANCER PATIENTS/

      Journal of allergy and clinical immunology
    23. FISK B; ANDERSON BW; GRAVITT KR; OBRIAN CA; KUDELKA AP; MURRAY JL; WHARTON JT; IOANNIDES CG
      IDENTIFICATION OF NATURALLY PROCESSED HUMAN OVARIAN PEPTIDES RECOGNIZED BY TUMOR-ASSOCIATED CD8(-LYMPHOCYTES() CYTOTOXIC T)

      Cancer research
    24. IOANNIDES CG; FISK B; MELICHAR B; ANDERSON B; STIFANI S; PAPAYANNOPOULOS CG; MURRAY JL; KUDELKA A; WHARTON JT
      OVARIAN AND BREAST CYTOTOXIC LYMPHOCYTES CAN RECOGNIZE PEPTIDES FROM THE AES PROTEIN OF THE NOTCH COMPLEX

      The FASEB journal
    25. FISK B; DAGUE B; SEIFERT WE; LAMBRIS JD; PAPAYANNOPOULOS I; KUDELKA A; WHARTON JT; IOANNIDES CG
      OVARIAN CYTOTOXIC T-LYMPHOCYTES CAN RECOGNIZE COMMON PEPTIDES PRESENTED BY HLA-A2+ TUMORS

      The FASEB journal
    26. MELICHAR B; HUDSON JM; HONDA T; TUTTLE T; MURRAY JL; WHARTON JT; IOANNIDES CG
      CHARACTERIZATION OF ANTIGEN RECOGNITION IN TUMOR-INFILTRATING LYMPHOCYTES IN BREAST-CANCER

      The FASEB journal
    27. FISK B; SAVARY C; HUDSON JM; OBRIAN CA; MURRAY JL; WHARTON JT; IOANNIDES CG
      CHANGES IN AN HER-2 PEPTIDE UP-REGULATING HLA-A2 EXPRESSION AFFECT BOTH CONFORMATIONAL EPITOPES AND CTL RECOGNITION - IMPLICATIONS FOR OPTIMIZATION OF ANTIGEN PRESENTATION AND TUMOR-SPECIFIC CTL INDUCTION

      Journal of immunotherapy with emphasis on tumor immunology
    28. BLEVINS TL; FISK B; WHARTON JT; KAVANAGH JJ; IOANNIDES CG; KUDELKA AP
      T-CELL PROLIFERATING RESPONSES TO HER-2 PEPTIDE ANALOGS IN OVARIAN-CANCER PATIENTS

      The FASEB journal
    29. FISK B; BLEVINS TL; WHARTON JR; IOANNIDES CG
      IDENTIFICATION OF AN IMMUNODOMINANT PEPTIDE OF HER-2 RECOGNIZED BY OVARIAN TUMOR-SPECIFIC CTL

      The FASEB journal
    30. FISK B; FLYTZANIS CN; POLLACK MS; WHARTON JT; IOANNIDES CG
      CHARACTERIZATION OF T-CELL RECEPTOR-V-BETA REPERTOIRE IN OVARIAN TUMOR-REACTING CD3(-) CTL LINES (VOL 40, PG 591, 1994)() CD8(+) CD4()

      Scandinavian journal of immunology
    31. FISK B; BLEVINS TL; WHARTON JT; IOANNIDES CG
      IDENTIFICATION OF AN IMMUNODOMINANT PEPTIDE OF HER-2 NEU PROTOONCOGENE RECOGNIZED BY OVARIAN TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTE LINES/

      The Journal of experimental medicine
    32. FISK B; IOANNIDES CG; AGGARWAL S; WHARTON JT; OBRIAN CA; RESTIFO N; GLISSON BS
      ENHANCED EXPRESSION OF HLA-A,B,C AND INDUCIBILITY OF TAP-1, TAP-2, AND HLA-A,B,C BY INTERFERON-GAMMA IN A MULTIDRUG-RESISTANT SMALL-CELL LUNG-CANCER LINE

      Lymphokine and cytokine research
    33. FREEDMAN RS; BOWEN JM; DELCOS L; EDWARDS CL; WALLACE S; ATKINSON EN; IOANNIDES CG; KASI LP; SCOTT W; PATENIA R
      ACTIVE INTRALYMPHATIC IMMUNOTHERAPY OF UTERINE CERVICAL-CARCINOMA WITH VIRAL ONCOLYSATE - A PILOT-STUDY

      International journal of gynecological cancer
    34. FISK B; CHESAK B; IOANNIDES MG; WHARTON JT; IOANNIDES CG
      SEQUENCE MOTIFS OF HUMAN HER-2 PROTOONCOGENE IMPORTANT FOR PEPTIDE BINDING TO HLA-A2

      International journal of oncology
    35. FISK B; FLYTZANES CN; POLLACK MS; WHARTON JT; IOANNIDES CG
      CHARACTERIZATION OF T-CELL RECEPTOR V-BETA REPERTOIRE IN OVARIAN TUMOR-REACTING CD3(-) CTL LINES()CD8(+)CD4()

      Scandinavian journal of immunology
    36. FISK B; CHESAK B; POLLACK MS; WHARTON JT; IOANNIDES CG
      OLIGOPEPTIDE INDUCTION OF A CYTOTOXIC T-LYMPHOCYTE RESPONSE TO HER-2 NEU PROTOONCOGENE IN-VITRO/

      Cellular immunology
    37. FISK B; FLYTZANIS CN; TUCKER SL; IOANNIDES CG
      DISSIMILAR TCR V-BETA FREQUENCIES IN TIL FROM DIFFERENT SITES OF THE SAME TUMOR

      International journal of oncology
    38. MAYER R; HAN A; FISK B; IOANNIDES CG
      COMMON TCR-BETA CHAIN REARRANGEMENTS IN SHORT-TERM CULTURED LYMPHOCYTES INFILTRATING OVARIAN-TUMORS

      International journal of oncology
    39. IOANNIDES CG; FISK B; JEROME KR; IRIMURA T; WHARTON JT; FINN OJ
      CYTOTOXIC T-CELLS FROM OVARIAN MALIGNANT-TUMORS CAN RECOGNIZE POLYMORPHIC EPITHELIAL MUCIN CORE PEPTIDES

      The Journal of immunology
    40. IOANNIDES CG; FISK B; FAN D; BIDDISON WE; WHARTON JT; OBRIAN CA
      CYTOTOXIC T-CELLS ISOLATED FROM OVARIAN MALIGNANT ASCITES RECOGNIZE APEPTIDE DERIVED FROM THE HER-2 NEU PROTOONCOGENE/

      Cellular immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 15:16:05